1. Home
  2. BLTE vs VAL Comparison

BLTE vs VAL Comparison

Compare BLTE & VAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$158.49

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Logo Valaris Limited

VAL

Valaris Limited

HOLD

Current Price

$102.41

Market Cap

6.4B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLTE
VAL
Founded
2018
1975
Country
United States
Bermuda
Employees
N/A
5070
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
6.4B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
BLTE
VAL
Price
$158.49
$102.41
Analyst Decision
Strong Buy
Hold
Analyst Count
7
5
Target Price
$198.00
$64.00
AVG Volume (30 Days)
117.4K
868.1K
Earning Date
05-08-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$492.11
$15.76
P/E Ratio
N/A
$16.22
Revenue Growth
N/A
N/A
52 Week Low
$56.68
$35.20
52 Week High
$200.00
$105.35

Technical Indicators

Market Signals
Indicator
BLTE
VAL
Relative Strength Index (RSI) 43.63 61.80
Support Level $157.63 $86.67
Resistance Level $161.28 $103.77
Average True Range (ATR) 6.26 3.62
MACD -1.15 0.96
Stochastic Oscillator 17.27 87.88

Price Performance

Historical Comparison
BLTE
VAL

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

About VAL Valaris Limited

Valaris Ltd is an offshore contract drilling company. The company provides offshore contract drilling services to the international oil and gas industry with operations in almost every offshore market across six continents. Its business consists of four operating segments: Floaters, which includes drillships and semisubmersible rigs; Jackups; ARO; and Other, which consists of management services on rigs owned by third parties. It generates the majority of its revenue from the Floaters segment.

Share on Social Networks: